ATHA Total Aset Bisnis Athira Pharma Inc

ATHA (Athira) - tandha merek perusahaan

Athira Pharma, Inc. (ATHA) specializes in developing innovative therapies for nervous system diseases. The visualization of the total asset market value, which stands at 58.14, reflects the company's financial condition, which depends on the outcomes of Alzheimer's drug trials and capital volume. The business potential relies on unique molecules that restore neural connections via the HGF/MET pathway, providing significant pricing power. Management is currently revising the development vector following the failure of the primary drug.

Gunggung Aset Perusahaan: Athira Pharma, Inc. (ATHA) kanggo 04.07.2022 - 12.01.2026

Rincian analitis lan laporan data perusahaan Athira (ATHA)

- nilai pasar lan prakiraan target analis:
Rega saham athira.com|ATHA - Bagan rega target
- data kapitalisasi pasar:
Kapitalisasi pasar Athira Pharma Corp|ATHA - Nilai Perusahaan
- informasi kapitalisasi buku:
Nilai Aset Bersih saben Saham Athira Pharma|ATHA - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku athira.com|ATHA - Aset Agregat Perusahaan
- indikator beban utang lan likuiditas:
Rasio Kabeh Utang marang Dana Pribadi Athira Pharma, Inc.|ATHA - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal Athira Pharma Corp|ATHA - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Athira Pharma Corp|ATHA - Kewajiban jangka dawa perusahaan|Gedhene kewajiban jangka cendhak Athira Pharma|Rasio jangkoan perantara athira.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
ATHA - Bathi resik
Pambiji fundamental:Athira Pharma, Inc.
Produk sing diprodhuksi Athira Pharma

To objectively assess the stability of Athira Pharma, Inc. (ATHA), investors must analyze the volume of resources, calculated inversely via return on assets (ROA), to track capital dynamics between reports. The trajectory of total assets (via ROA) demonstrates the effectiveness of cost restructuring and the company's ability to fund the development of second-generation molecules amid a strategic transition following the failures of its flagship drug.

Pesaing wigati

biogen.com (BIIB) - Total Aset Perusahaan|Aset Agregat Perusahaan Neurocrine Biosciences, Inc.|Total Aset Bisnis RGC (Regencell Bioscience Ltd)|Total Aset Perusahaan AXSM|ACAD - Aset Perusahaan|Xenon Pharmaceuticals - Gunggung Aset Perusahaan|Total Aset Perusahaan vikingtherapeutics.com VKTX|SUPN - Aset Agregat Perusahaan|Nilai Agregat Aset CPRX (Catalyst Pharma)|Denali Therapeutics Inc (DNLI) - Aset Agregat Perusahaan|Aset Perusahaan Harmony Corp (HRMY)|BHVN (Biohaven Ltd.) - Total Aset Perusahaan|Total Aset Perusahaan amylyx.com|Gunggung Aset Perusahaan TRVI (Trevi Therapeutics, Inc.)|Aset Agregat Bisnis PRAX|Total Aset Perusahaan AVXL (Anavex Corp)|Nilai Agregat Aset CBLL|Prothena Corporation plc - Total Aset Perusahaan|Gunggung Aset Perusahaan Alector, Inc. ALEC|Annexon (ANNX) - Aset Agregat Perusahaan|Omeros - Nilai Agregat Aset|NGNE (Neurogene Corp) - Total Aset Perusahaan|Total Aset Perusahaan AC Immune Inc|Gunggung Aset Perusahaan VYGR (Voyager Therapeutics)|NMRA (neumoratx.com) - Nilai Agregat Aset|Aset Agregat Perusahaan Scilex SCLX|TVGN (Tevogen Bio Holdings Inc.) - Nilai Total Aset Perusahaan|Alpha Cognition Corp - Total Aset Perusahaan|Nilai Agregat Aset CGTX (Cognition Therapeutics Inc.)|IKT: Total Aset Perusahaan|cassavasciences.com (SAVA) - Total Aset Perusahaan|Aset Agregat Perusahaan Assertio Holdings|COYA: Nilai Agregat Aset|Aset Agregat Perusahaan Vistagen Therapeutics (VTGN)|Gunggung Aset Perusahaan ovidrx.com OVID|Total Aset Perusahaan ABOS (Acumen Pharmaceuticals)|Total Aset Perusahaan cervomed.com CRVO|ATHE: Gunggung Aset Perusahaan|Nilai Agregat Aset CLNN (Clene Inc.)|PEPG: Total Aset Perusahaan|JUNS - Gunggung Aset Perusahaan|Aset Agregat Perusahaan Relmada Therapeutics|Total Aset Bisnis ANVS (annovisbio.com)|Total Aset Perusahaan GRCE|Gunggung Aset Perusahaan Firefly Neuroscience, Inc. AIFF|Klotho Neurosciences - Gunggung Aset Perusahaan|Gunggung Aset Perusahaan NeuroSense Therapeutics Ltd (NRSN)|Reviva Pharmaceuticals - Total Aset Perusahaan|MTVA - Total Aset Perusahaan|NRXS (NeurAxis) - Gunggung Aset Perusahaan|HSDT: Aset Agregat Bisnis|PASG (Passage Bio Inc.) - Total Aset Perusahaan|NEUP: Nilai Agregat Aset|Total Aset Perusahaan NERV|Total Aset Perusahaan addextherapeutics.com (ADXN)|Aset Agregat Perusahaan Alzamend Neuro ALZN|CYCN: Total Aset Bisnis|Protagenic - Total Aset Perusahaan|Aset Perusahaan Pasithea Therapeutics|CRGT (cortigent.com) - Gunggung Aset Perusahaan|avenuetx.com (ATXI) - Total Aset Perusahaan|Aset Agregat Perusahaan BrainStorm Cell Therapeutics|CARA: Nilai Agregat Aset|Aset Agregat Perusahaan Chromocell Therapeutics Corporation (CHRO)|ELYM - Aset Perusahaan|Total Aset Perusahaan ITCI (Intra-Cellular Therapies, Inc.)|Total Aset Perusahaan longboardpharma.com LBPH|MRNS: Gunggung Aset Perusahaan|NKGen Biotech Inc - Aset Agregat Bisnis|NRBO: Total Aset Perusahaan|Sage Therapeutics Inc - Nilai Agregat Aset|SNPX (Synaptogenix, Inc.) - Total Aset Perusahaan|trevena.com (TRVN) - Gunggung Aset Perusahaan|Aset Agregat Perusahaan Vigil Neuroscience (VIGL)|WENA (anewmeds.com) - Nilai Agregat Aset|Total Aset Perusahaan CERE (Cerevel)